Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TIVC - 1.49 Up .43
Tivic Health Announces Completion Of Non-Invasive VNS Study Demonstrating Effective Biological Changes In The Autonomic, Cardiac, And Central Nervous Systems
REBN - 3.65 Up 1.90
Reborn Coffee shares are trading higher after the company announced a significant expansion into the China market through a strategic Master License Agreement with IAID Co.
Stocks with buying interest early AM:
SLNH
ISUN
ENVB
CLOV
HSDT
FRSX
INOD
PERI
TCBP - 1.56/1.57 Up from 1.45
TC BioPharm shares are trading higher after the company announced the execution of a non-binding letter of intent to acquire a company pursuing the development of innovative CAR-T therapies for the treatment of refractory cancers and solid tumors.
FGEN - 1.35/1.36 Up from 1.16
FibroGen Q1 2024 GAAP EPS $(0.33) Misses $(0.31) Estimate, Sales $55.902M Beat $36.666M Estimate
CMND - 1.68/1.69 Up from 1.17
Clearmind Medicine Signs Exclusive Patent Licensing Agreement With Yissum Research Development Company; Under Agreement, Clearmind Receives Exclusive Rights To Develop, Manufacture, And Commercialize Novel Compounds For Treating PTSD And Other Mental Health Disorders
More Stocks with buying interest early AM:
CMND
NUWE
EVGO
HRTX
ZKIN
IBRX
Stocks with buying interest early AM:
AIRE
FGEN
TCBP
BURU - .2812/.283 Up from .23
Nuburu Inc Awarded $850,000 Phase II Contract With NASA For Blue Laser Space Technology, Co's To Demonstrate Feasibility Of Surface Power Management Solutions Using Blue Laser Technology
TCBP - 1.91/1.93 Up from 1.46
TC BioPharm Announces Execution Of Second Non-Binding LOI For Acquisition, Targeting Innovative CAR-T Therapies; Financial Terms Not Disclosed
ALLR - 1.17/1.18 Up from 1.00
Allarity Therapeutics shares are trading higher after the company announced that its stockholders' equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule and will submit a request to the SEC to withdraw Form S-1.
LILM - 1.15/1.16 Up from 1.04
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator UrbanLink
PSTV - 2.06/2.07 Up from 1.80
Press Release: Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Stocks with buying interest early AM:
BENF
GRFX
SBFM
LILM
WULF
CTMX
SGBX - 3.68/3.71 Up from 2.93
Safe & Green Holdings' Subsidiary, SG Echo, Is Preparing To Deliveral Its Modular Unit To A Prominent Quick-Service Restaurant Customer In The Pacific Northwest
IBRX - 9.45/9.50 Up from 8.97
ImmunityBio shares are trading higher after the company announced it signed an exclusive global arrangement with the Serum Institute of India. The company will be supplied with Bacillus Calmette-Guerin.
HSDT - 3.73/3.74 Up from 2..66
Helius Medical Technologies Expands Stroke Clinical Program With Participation Of Shepherd Center
Stocks with buying interest early AM:
HSDT
HCTI
FUBO
ARDX
ORGN
SBFM
PLUG
IBRX
NUWE - .2352/.2370 UP .1051
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
SGBX - 3.20 Up 3.10
Safe and Green Holdings Announces Collaboration and Sales of Modular Units to Britten Inc.
ORGO - 2.73/2.80 UP from 2.51
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
ASNS - .92/.9209 Up from .7899
Actelis Receives $2.3M Order For Immediate Delivery Of New Hybrid-Fiber Intelligent Networking Solution For Washington D.C.'s Department Of Transportation
HUBC - 1.21/1.22 Up from 1.05
HUB Cyber Security shares are trading higher after the company was awarded a $2M contract by the Israeli Airports Authority.
CNTX - 1.84/1.85 Up from 1.36
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
Context Therapeutics Announces $100 Million Private Placement
ALLR - 2.97/2.98 Up from 1.37
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
Stocks with buying interest early AM:
ALLR
CNTX
APVO
HUBC
ORGO
KSCP
RIOT
SOUN
BLNK
WULF
PALI - 8.57/8.65 Up from 6.03
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
AGBA - 3.21/3.22 UP from 2.83
AGBA Merger With Triller Expected To Drive Scaling Up To Leverage Fast-Emerging Opportunities In A Highly Favorable Market Environment; Developing Monetization Capabilities Through Advanced Technologies And Innovative Marketing Strategies; Identifying And Executing Strategic Acquisitions And Partnerships To Accelerate Our Path Towards Becoming A Global Powerhouse In Digital Media And Financial Services.
IMCC - 1.16/1.17 Up from .86
Shares of cannabis-related stocks are trading higher following reports suggesting the DEA plans to reclassify cannabis as a less dangerous drug.
POAI - 1.74/1.75 Up from 1.41
Predictive Oncology Announces Progress With FluGen In the Development Of First-Of-Its-Kind Intranasal Flu Vaccine, As Part Of A $6.2M Phase 2B Grant Awarded By The U.S. DOD
Stocks with buying interest early AM:
AKAN
IMCC
POAI
TGTX
GETR
LGHL
NAOV
DNN
IGC
UAVS - .7745/.7779 Up from .697
AgEagle Announces $3.4M Drone (UAV) Sale to French Army
AUUD - 1.99/2.00 UP from1.65
Auddia Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natural Language Processing Offering
MRIN - 3.33/3.35 Up from 2.61
Marin Software Launches AI-powered Anomaly Detector To Unlock Growth In Performance Marketing Campaigns; Says "Tool Automatically Identifies And Summarizes Unexpected Results In Performance Marketing Campaigns Across Google, Meta, Amazon, And Other Pay-Per-Click Ad Platforms"
MULN - 6.94/6.96 Up from 5.72
Mullen Automotive shares are trading higher after the company announced the California Air Resources Board has approved the 2024 Mullen THREE for the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project.
AKLI - .39/.3901 Up from .2349
Akili Announces Amended Agreement With Shionogi, Shionogi Has Canceled And Forgiven A $5M Long-Term Debt Obligation And Agreed To Make Certain Payments For SDT-001 (The Japanese, Localized Version Of Akili's AKL-T01 Digital Treatment, Marketed As EndeavorRx In The U.S.)
BRTX - 1.66/1.67 Up from 1.24
BioRestorative Therapies shares are trading higher after the company announced that it entered into a five-year exclusive supply agreement with Cartessa Aesthetics.
Stocks with buying interest early AM:
CYCC
BRTX
MRIN
MULN
AUUD
LLY
CYCC - 2.02/2.03 Up from 1.36
Cyclacel Pharmaceuticals shares are trading higher after the company announced that it filed Form RW with the SEC, withdrawing its registration statement on Form S-1. The company also announced an $8 million private placement.
NKGN - 1.90/1.91 Up from 1.61
NKGen Biotech Announces FDA Clearance Of IND Application For SNK01 NK Cell Therapy in Parkinson's Disease
IBRX - 8.05/8.07 Up from 7.35
ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.
CAUD - .626/.64 Up from .39
Collective Audience and Insticator Launch Strategic Partnership, Integrating AudienceCloud™ with Insticator’s Reach to 350 Million Consumers Monthly
BMRA - .753/.7533 Up from .665
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
ARQQ - .59/.5928 Up from 4877
Arqit Quantum shares are trading higher after the company announced its partnership with Intel to launch Quantum-Safe, 1.89 Tb IPsec products.
Stocks with buying interest early AM:Stocks:
ARQQ
IBRX
BMRA
ZVSA
SLNO
AIRI
DTIL
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |